Skip to main content
SpringerLink
Log in

Medikamentöse Prophylaxe bei peripheren arteriellen Durchblutungsstörungen

  • Chapter
Klinische Angiologie

Zusammenfassung

Man unterscheidet eine Primär- von einer Sekundärprophylaxe. Die Primärprophylaxe hat das Ziel, eine bestimmte Erkrankung gar nicht erst auftreten zu lassen (primäre Prävention). Bei der Sekundärprophylaxe geht es allgemein darum, bei bereits eingetretener Erkrankung eine Krankheitsprogredienz oder ein Rezidiv zu verhüten (Sekundärprävention).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 349.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

14.1–14.5

  • Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RR, Sigmon K, Taylor M, Gottlieb R, Hanovich G, Rosenberg M, Donohue TJ, Weisman HF, Califf RM (1995) Bleeding complications with the chimeric antibody to platelet glycoprotein Ilb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 91:2882–2890

    Article  PubMed  CAS  Google Scholar 

  • Albert JP, Regensburger D, Rudolf H (1982) Rezidivprophylaxe operativ korrigierter Arterienverschlüsse der unteren Extremitäten. Med Welt 33:1829–1831

    PubMed  CAS  Google Scholar 

  • Alfke H, Böger RH, Bode-Böger SM (1996) Restenose nach perkutaner transluminaler Angioplastie — Ätiologie und klinische Bedeutung. VASA 25:13–20

    PubMed  CAS  Google Scholar 

  • Allegra C, Pollari G, Carioti B, Sardina M (1994), Thrombin and platelet inhibition with low dose calcium heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class. Int J Clin Pharmacol Ther 32:646–651

    PubMed  CAS  Google Scholar 

  • Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomised trials of antiplatetel therapy. Br Med J 308; 159–168

    Article  Google Scholar 

  • Antman EM, for the TIMI 9A investigators (1994) Hirudin in acute myocardial infarction; Safety report from the thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9A trial. Circulation 90:1624–1630

    Article  PubMed  CAS  Google Scholar 

  • Antman EM, for the TIMI 9B investigators (1996) Hirudin in acute myocardial. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation 94:911–921

    Article  PubMed  CAS  Google Scholar 

  • Antonovic R, Rösch J, Dotter CT (1976) The value of systemic arterial heparinization in transfemoral angiography: A prospective study. Am J Roentgenol 127:223–225

    Article  CAS  Google Scholar 

  • Balsano F, Coccheri S, Libretti A, Nenci GG, Catalano M, Fortunato G, Grasselli S, Violi F, Hellemans H, Vanhove PH (1989) Ticlopidine in the treatment of intermittent claudication: A 21 month double blind trial. J Lab Clin Med 114:84:91

    PubMed  CAS  Google Scholar 

  • Beilage für den Kardiologen (1995) Z Kardiol 84/2

    Google Scholar 

  • Böger RH, Bode-Böger SM, Alfke H (1996) Restnose nach perkutaner transluminaler Angioplastie: Möglichkeiten der pharmakologischen Intervention. VASA 25:21–32

    PubMed  Google Scholar 

  • Bollinger A, Brunner U (1985) Antiplatelat drugs improve the patency rates after femoro-popliteal endarterectomy. VASA 14:272–279

    PubMed  CAS  Google Scholar 

  • Breddin K (1994) Hirudin als antithrombotisches Medikament: In: Tilsner V, Matthias FR (Hrsg) Trombophilie und Antikoagulation. Roche, Basel, S 73–82

    Google Scholar 

  • Breddin HK, Radziwon P, Keppler S (1995) Methods to monitor the effects of platelet membrane glycoprotein IIb/IIIa-inhibitors. XIIIth meeting of the international Society of Haematology (European and African division). Turkish J Haematol 14, Suppl 1, Abstr 264

    Google Scholar 

  • Breddin HK, Radziwon P, Eschenfelder V, Müller-Peltzer H, Esslinger HU (1996) PEG-hirudin and acetylsalicylic acid show a strong interaction on bleeding time. Ann of Haematology 72, Suppl I. A 53

    Google Scholar 

  • Broomé A, Davidsson T, Eklöf B, Hansson L (1982) Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with goretex protheses a retrospective study. VASA 11:210–212

    PubMed  Google Scholar 

  • Bruhn HD (1993) Niedrigdosiertes Heparin. Schattauer, Stuttgart

    Google Scholar 

  • Bruhn HD, Zurborn KH (1995) Analyse der individuellen Qualität einer oralen Antikoagulation durch den Quotienten F1 + 2/INR. Dtsch Med Wochenschr 120:1441–1444

    Article  PubMed  CAS  Google Scholar 

  • Bruhn HD, Jipp P, Schellmann J, Sedlmayer S, Müller-Wiefel H, Borm D (1972) Zur Antikoagulantienprophylaxe bei chirurgischer und konservativer Therapie chronischer Becken-Bein-Arterienverschlüsse. Med Klin 67:1514:1519

    PubMed  CAS  Google Scholar 

  • Brunner U, Bollinger A, Schneider E, Witschi B (1979) Endarteriektomie und autologer Venenbypass: Rezidivprophylaxe mit Aggregationshemmern und Antikoagulantien. In: Wagener O, Kubina VK (Hrsg) Der Rezidiwerschluß nach Gefäßkonstruktionen an der unteren Extremität. Eger-mann, Wien, S 99–107

    Google Scholar 

  • Buddecke E (1996) Non-anticoagulant functions of heparin and heparan sulfate. Hämostaseologie 16:6–14

    CAS  Google Scholar 

  • Burkhalter A, Widmer LK, Glans L (1974) Chronischer Gliedmaßenverschluß und Langzeitantikoagulation. VASA 3:185–189

    PubMed  CAS  Google Scholar 

  • Cannon CP, McCabe CH, Henry TD, Schweiger MC, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland M, Anderson JL, Sharaf BL, Edwards SJ, Rogers WJ, Williams DO, Braunwald E (1994) A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue type plasminogen activator and aspirin for acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 5 tial. J Am Coll Cardiol 23:993–1003

    Article  PubMed  CAS  Google Scholar 

  • CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

    Article  Google Scholar 

  • Clagett GP, Genton E, Salzman EW (1989) Antithrombotic therapy in peripheral vascular disease. Chest 95:128S–139S

    PubMed  CAS  Google Scholar 

  • Clemetson KJ Platelet activation (1995) Signal transduction via membrane receptors. Thrombos Haemostas 74:111–116

    CAS  Google Scholar 

  • Clyne CAC, Archer TJ, Atuhaire LK, Chant ADB, Webster JHH (1987) Random control trial of a short sourse of aspirin and dipyridamole (Persantin) for fomorodistal grafts. Br J Surg 74:246–248

    Article  PubMed  CAS  Google Scholar 

  • Currier JW, Thomas K, Minihan AC, Haudenschild DD, Faxon DP, Ryan TJ (1989) Colchicine inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. Circulation 80 [Suppl]:11–66

    Google Scholar 

  • De Smit P, Van Urk H (1988) The effects of longterm treatment with oral anticoagulants in patients with peripheral vascular disease. In: Tilsner V, Matthias FR (Hrsg) Arterielle Verschlußkrankheit und Blutgerinnung. Roche, Basel Grenzach-Whylen, pp 211–216

    Google Scholar 

  • Edmondson RA, Cohen AT, Das SK, Wagner MG, Kakkar VV (1994) Low-molecular weight heparin vesus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet 344:914–918

    Article  PubMed  CAS  Google Scholar 

  • Ehresmann U, Alemany J, Loew D (1977) Prophylaxe von Rezidiwerschlüssen nach Revaskularisationseingriffen mit Acetylsalicylsäure. Med Welt 28:1157–1162

    PubMed  CAS  Google Scholar 

  • Ehringer H, Marosi L, Schöfl R (1986) Reduction of thrombotic layers on the now inner vessel wall following thrombendarterectomy (TEA) of the carotid artery by means of ASA (10 g/day) treatment. In: Maurer CP, Becker HM, Heidrich H et al. (eds) What is new in angiology? — Trends and controversies. Zuckschwerdt, München Bern Wien, pp 298–300

    Google Scholar 

  • EPIC-Investigators (1994) Use of a monoclonal antibody directed against the poatelet glycoprotein Ilb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 330:956–961

    Article  Google Scholar 

  • Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P (1994) Direct thrombin inhibition with rec-Hirudin CGP 39393 as prohylaxis of thromboembolic complications after total hip replacement. Thombos Haemostas 74:227–231

    Google Scholar 

  • Fuster V, Chesebro JH (1986) Role of platelets and platelet inhibitors in aorto coronary vein graft disease. Circulation 73:227–232

    Article  PubMed  CAS  Google Scholar 

  • Gabriel SE, Jaakkimainen L, Bombardier (1991) Risk for serious gastrointestinal complications related to use of non steroidal anti-inflammatory drugs. A Meta-Analysis. Ann Int Med 115:787–794

    Article  PubMed  CAS  Google Scholar 

  • Gallino A, Mahler F, Probst P, Nachbur B (1984) Perentaneous transluminal angioplasty of the arteries of the lower limbs. 25 years follow-up circulation 70:619–623

    Article  CAS  Google Scholar 

  • Giercksky HE, Huseby G, Rugstad HE (1989) Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol [Suppl 163] 24:3

    Article  CAS  Google Scholar 

  • Girod DA, Horwitz RA, Caldwell RL (1982) Heparinization for prevention of thromboses following pediatric percutaneous arterial catheterization. Pediatr Cardiol 3:175:179

    Article  PubMed  CAS  Google Scholar 

  • Goldhaber SZ, Manson JE, Stampfer MJ, Lamotte F, Rosner B, Buring JE, Hennekens CH (1991) Aspirin and peripheral arterial surgery in the physicians health study. Circulation 84 [Suppl II]: 335–339

    Google Scholar 

  • Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN (1983) Aspirin and Dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Ann Surg 198:713–716

    Article  PubMed  CAS  Google Scholar 

  • Green RM, Roedersheimer RL, DeWeese JA (1982) Effects of aspirin and dipyridamole on expanded plytetrafluorethylene graft patency. Surgery 92:1016–1026

    PubMed  CAS  Google Scholar 

  • Greinacher A, Alban S (1996) Heparinoide als Alternative für die parenterale Antikoagulation bei Patienten mit Heparininduzierter Thrombozytopenie. Hämostaseologie 16:41–49

    CAS  Google Scholar 

  • Gross R (1992) Zur kardiovaskulären Protektion durch Aspirin (ASS). Dtsch Ärztebl 89:1820–1824

    Google Scholar 

  • Grüntzig A (1977) Die perkutane transluminale Rekanalisation chronischer Arterienverschlüsse mit einer neuen Dilatationstechnik. Baden-Baden, Witzstrock

    Google Scholar 

  • The global use of strategies to open occluded coronary arteries (GUSTO) IIb investigators (1994) Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes, Circulation 90:1631–1637

    Article  Google Scholar 

  • The global use of strageties to open occluded coronary arteries (GUSTO) IIb investigators (1996) A comparison of recombinant hirudin with heparin fot he treatment of acute coronary syndromes, NEJM 335:775–782

    Article  Google Scholar 

  • Gutberiet H, Rösch W (1992) Nebenwirkungen von Azetylsalizylsäure auf Magen und Duodenum. Klinikarzt 21:449–452

    Google Scholar 

  • Hafner J, Moerioose P, Bounameaux H (1996) Oral anticoagulation alone or in combination with aspirin: risks and benefits. VASA 25:1–6

    PubMed  CAS  Google Scholar 

  • Hagen PO, Wang ZG, Mikat EM, Hackel B (1982) Antiplatelet therapy reduces aortic intimai hyperplasia distal to small diameter vascular prostheses (PTEE) in non-human primates. Ann Surg 195:328–343

    Article  PubMed  CAS  Google Scholar 

  • Harenberg J, Leber G, Augustin J (1987) Ambulante Langzeitprophylaxe der Thromoembolie mit niedermolekularem Heparin. Klin Wochenschr 65:331–337

    Article  PubMed  CAS  Google Scholar 

  • Heiss HW, Just H, Middleton D, Deichsel G (1990) Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Angiology 41:263–269

    Article  PubMed  CAS  Google Scholar 

  • Herrman JPR, Simon R, Umans VAWM, Peerboom PF, Keane D, Runierse JJMM, Bach D, Kobi P, Kerry R, Close P, Deckers JW, Serruys PW (1995) Evaluation of recombinant hirudin (CGP 39 393/registered REVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the Helvetica trial, a multicentre randomized double blind heparin controlled study. Eur Heart J 16 Suppl L: 56–62

    Article  PubMed  CAS  Google Scholar 

  • Hess H (1967) Die Antikoagulantien-und Fibrinolysebehandlung bei arteriellen Gefäßverschlüssen. Therapiewoche 17:1617–1619

    Google Scholar 

  • Hess H, Keil-Kuri E (1975) Theoretische Grundlagen der Prophylaxe obliterierender Arteriopathien mit Aggregationshemmer und Ergebnisse einer Langzeitstudie mit ASS (Colfarit). In: Marx R, Breddin HK (eds) Colfarit-Symposium III. Bayer, Köln, S 80–87

    Google Scholar 

  • Hess H, Müller-Fassbender H, Ingrisch H, Mietaschk (1978) Verhütung von Wiederverschlüssen nach Rekanalisation obliterativer Arterien mit der Kathetermethode. Dtsch Med Wochenschr 103:1994–1997

    Article  PubMed  CAS  Google Scholar 

  • Hess H, Mietaschk A, Deichsel G (1985) Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet 1:415–419

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann E (1996) Selbstkontrolle der oralen Antikoagulation aus der Sicht der Patienten. Dtsch Ärztebl 93:1034–1035 u

    Google Scholar 

  • Jäger D, Drews S, Huppe D, Machraoui A, Krieg M, Barmeyer J (1994) Erfolgreiche Fibrinolysetherapie der frühzeitig diagnostizierten Cumarinnekrose. Med Klin 87:334–338

    Google Scholar 

  • Kaufmann U, Meier B (1997) Derzeitiger Stand der Stentimplantation. Der Internist 38:20–26

    PubMed  CAS  Google Scholar 

  • Kemkes-Matthes B (1994) Orale Antikoagulanzien. In: Hach-Wunderle V, Neuhaus KL (Hrsg) Thrombolyse und Antikoagulanzien in der Kardiologie. Springer, Berlin Heidelberg New York Tokyo, S 39–45

    Chapter  Google Scholar 

  • Kitchingman, GK, Prichard PJ, Daneshmend TK et al. (1989) Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidin. Br J Clin Pharma 28:581–585

    Article  CAS  Google Scholar 

  • Kohler TR, Kaufmann IL, Kacoyanis G, Clowes A, Donaldson MC, Kelly E, Skilimann J, Couch NP, Whittemore AD, Mannick JA, Salzman EW (1984) Effect of aspirin and dipyridamole on the patency of lower extremity bypass graft. Surgery 96:462–4668

    PubMed  CAS  Google Scholar 

  • Koller F, Loeliger EA (1983) In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 335–352

    Google Scholar 

  • Krepel VM, Ande GJ van, Erp WFM van, Breslau PJ (1985) Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long term results. Radiology 156:325–328

    PubMed  CAS  Google Scholar 

  • Kretschmer G, Schemper M, Ehringer H, Wenzel E, Polterauer P, Marcosi L, Minar E (1988) Influence of postoperative anticoagulant treatment on patient survival after femoro-popliteal vein bypass surgery. Lancet 1:797–799

    Article  PubMed  CAS  Google Scholar 

  • Kurata JH, Abbey DE (1990) The effect of chronic aspirin use on duodenal and gastric ulcer hispotalizations. J Clin Gastroenterol 12:260–264

    Article  PubMed  CAS  Google Scholar 

  • Laporte JR, Carne X, Vidal X, Moreno V, Juan J (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non steroidal antiinflammatory drugs. Lancet 337:85–89

    Article  PubMed  CAS  Google Scholar 

  • Laudefeld CS, Beyth RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 95:315–328

    Article  Google Scholar 

  • Lefkovits J, Plow EF, Topol EJ (1995) Mechanisms of disease: Platelet glycoprotein Ilb/IIIa receptors in cardiovascular medicine. N Engl J Med 332:1553–1559

    Article  PubMed  CAS  Google Scholar 

  • Lengfelder W (1995) Aktueller Stand der antithrombotischen Therapie. Dtsch med Wschr 120:105–110

    Article  PubMed  CAS  Google Scholar 

  • Lidon RM, Theroux P, Lesperance J, Adelman B, Bonan R, Duval D, Levesque J (1994) A pilot, early angiographic patency study using a direct thrombin inhibitor as ad-junctive therapy to streptokinase in acute myocardial infarction. Circulation 89:1567–1572.

    Article  PubMed  CAS  Google Scholar 

  • Linke H (1975) Langzeitprophylaxe mit ASS (Colfarit) bei arteriellen Angiopathien, insbesondere bei der Angiopa-thia diabetica. Marx R, Breddin HK (eds) Colfarit Symposium III. Bayer, Köln, S 88–103

    Google Scholar 

  • Lüscher TF, Oemar BS, Yang Z, Noll G (1996) Molekulare und zelluläre Mechanismen der Arteriosklerose und Restenose: Möglichkeiten der Gentherapie. Z Kardiol 85:495–508

    PubMed  Google Scholar 

  • Mahler F, Schneider E, Gallino A, Bollinger A (1987) Combination of Suloctidil and anticoagulation in the prevention of reocclusion after femoropopliteal PTA. Vasa 16:381–385

    PubMed  CAS  Google Scholar 

  • Mannarino E, Pasqualini L, Innocente S, Orlandi U, Scricciolo V, Lombardini R, Cinfetti G (1991) Efficacy of low-molecular-weight-heparin in the management of intermittent claudication. Angiology 42:1–7

    Article  PubMed  CAS  Google Scholar 

  • Manson JE, Stampfer MJ, Colditz GA, Willett WS, Rosner B (1991) A prospective study of aspirin use and primary prevention of cardiovascular diesease in women. Circulation 83:722–729

    Google Scholar 

  • Markert T, Bertsch G, Langenfeld H, Schanzenbächer P (1996) Elektive koronare Implantation eines neu entwickelten Stents ohne klassische Antikoagulation. Dtsch Med Wochenschr 121:1213–1219

    Article  PubMed  CAS  Google Scholar 

  • Marx A, Messing A, Stroch B, Busse O (1987) Spontane Dissektionen hirnversorgender Arterien. Nervenarzt 58:8–18

    PubMed  CAS  Google Scholar 

  • Mehta A, Mehta JL (1989) Prophylactic aspirin use among US Physicians. Am J Cardiol 63:370:376

    Article  PubMed  CAS  Google Scholar 

  • Meyer BJ (1996) Neue Ansätze der antithrombotischen Behandlung während Koronarinterventionen. Schweiz Med Wschr 126:1961–1969

    PubMed  CAS  Google Scholar 

  • Minar E, Ahmadi A, Koppensteiner R, Maca T, Stumpften A, Ugurluoglu A, Ehringer H (1995) Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 91:2167–2173

    Article  PubMed  CAS  Google Scholar 

  • Minar E (1993) Antikoagulatientherapie der tiefen Beinvenenthrombose. Phlebologie 21:103–110

    Google Scholar 

  • Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK, De Grado WF, Thoolen MJ, Reilly TM (1994) Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GBIIb/IIIa receptor antagonist. Circulation 89:3–12

    Article  PubMed  CAS  Google Scholar 

  • Müllges W, Ringelstein EB, Weiller C, Leibold M, Brückmann H (1991) Dissektionen der A. carotis interna — neue diagnostische und pathogenetische Aspekte. Fortschr Neurol Psychiat 59:12–24

    Article  PubMed  Google Scholar 

  • Müller R, Kuhn H, Powell J (1989) Converting enzyme inhibitors reduce intimai Hyperplasia after balloon catheter induced vascular injury. Circulation 80 [Suppl]: II–63

    Google Scholar 

  • Neuhaus KL, v. Essen R, Tebbe U, Jessel A, Heinrichs H, Maurer W, Döring W, Harmjanz D, Kötier V, Kaihammer E, Simon H, Horacek T (1994) Safety observations from the pilot phase of the randomized r-hirudin for improvement of thrombolysis (HIT III) study. Circulation 90:1638–1642

    Article  PubMed  CAS  Google Scholar 

  • Nova KG, Bucha E (1995) Piothrombin conversion intermediate effectively neutralizes toxic levels of Hirudin. Thromb. Res. 80:317–325

    Article  Google Scholar 

  • Nunes GL, Hanson SR, King SB, Sahatjian RA, Scott NA (1994) Local delivery of a synthetic antithrombin with a hydrogel-coated angioplastx balloon catheter inhibits platelet dependent thrombosis. J Am Coll Cardiol 23:1578:1583

    Article  PubMed  CAS  Google Scholar 

  • Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA (1978) Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84:37–44

    PubMed  CAS  Google Scholar 

  • Partsch H (1996): Diagnose und Therapie der tiefen Venenthrombose. VASA, Suppl 46:33

    Google Scholar 

  • Peto R, Gray R, Collins R, Wheatley K, Hennekens C (1988) A randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 296:313:321

    Article  CAS  Google Scholar 

  • Pongratz G, Pohle K, Stingi D, Bachmann K (1995) Thrombozytenaktivierung und Thrombozytenaggregation am arteriosklerotisch veränderten Endothel. Dtsch Med Wochenschr 120:1009–1014

    Article  PubMed  CAS  Google Scholar 

  • Pow TK, Currier JW, Minihan AC, Haudenschild CC, Ryan TJ, Faxon DP (1989) Low molecular weight heparin reduces restenosis after experimental angioplasty. Circulation 80 [Suppl]: II–64

    Google Scholar 

  • Raithel D, Kaprzak P, Noppeney T et al. (1986) Rezidivprophylaxe nach femoropoplitealer Rekonstruktion mit PTFE-Prothesen. Med. Welt 37:644–650

    Google Scholar 

  • Ranke C, Creutzig A, Luska G, Wagner HH, Galanski M, Bode-Böger S, Frölich J, Avenarius HJ, Hecker H, Alexander K (1994) Controlled trial of high versus low dose aspirin treatment aftre percutaneous transluminal angioplasty in patients with peripheral vascular disease. Clin invest. 72:673–680

    Article  CAS  Google Scholar 

  • Saggau W (1977) Antikoagulantientherapie in der Gefäßchirurgie. In: Marx R, Thies HL (eds) Klinische und ambulante Anwendung klassischer Antikoagulantien. Schattauer, Stuttgart New York, S 171–176

    Google Scholar 

  • Schneider AW, Fechler L, Gilfrich HJ (1996) Ticlopidin-induzierte Panzytopenie: Therapie der Agranulozytose mit granulozytenkoloniestimulierendem Faktor. Med Klin 91:417–419

    CAS  Google Scholar 

  • Schoop W (1984) Prognose und Prophylaxe der peripheren arteriellen Verschlußkrankheit. In: Trübestein C (Hrsg) Arterielle Verschlußkrankheit und tiefe Beinvenenthrombose. Thieme, Stuttgart, S 172–176

    Google Scholar 

  • Schrör K (1992) Acetylsalicylsäure. Thieme, Stuttgart

    Google Scholar 

  • Schrör K (1993) The basic pharmacology of Ticlopidine and Clopidogrel, Platelets 4:252–261

    Article  PubMed  Google Scholar 

  • Schroer K (1996) Grundlagen der antithrombotischen Wirkung von Acetylsalicylsäure, in: K Schroer, HK Breddin (Hrsg) Acetylsalicylsäure im kardiovaskulären System; 50 Jahre nach Felix Hoffmann, Birkhäuser Verl. Basel, Boston, Berlin, S 36–61

    Chapter  Google Scholar 

  • Simon B, Kleinsorge H, Müller P (1993) Vergleich der gastroduodenalen Verträglichkeit von Ticlopidin und Acetylsalizylsäure. Dtsch Med Wochenschr 118:1146–1149

    Article  PubMed  CAS  Google Scholar 

  • Sinzinger H, O’Grady J, Fitscha P (1988) Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dpiyridamole. J Int Med Res 16:39–43

    PubMed  CAS  Google Scholar 

  • Staiger J, Mathias K, Friedrich M, Heiss HW, Konrad S, Spillner G (1980) Perkutane Katheterkanalisation (Dotter-Technik) bei peripherer arterieller Verschlußkrankheit. Herz/ Kreisl 9:383–386

    Google Scholar 

  • Stein PD, Kantrowitz A (1989) Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 95:1078–1178

    Article  Google Scholar 

  • Steinke W, Aulich A, Hennerici M (1989) Diagnose und Verlauf von Carotisdissektionen. Dtsch Med Wochenschr 114:1869–1875

    Article  PubMed  CAS  Google Scholar 

  • Stiegler H, Hess H, Mietasch K, Trampisol HJ, Ingrisch H (1984) Einfluß von Ticlopidin auf die periphere obliterierende Arteriopathie. Dtsch Med Wochenschr 109:1240–1243

    Article  PubMed  CAS  Google Scholar 

  • Stokes KR, Strunk HM, Campbell DR, Gibbons GW, Wheeler HG, Clouse ME (1990) 5 year results of iliac and femoropopliteal angioplasty in diabetic patients. Radiology 174:977–982

    PubMed  CAS  Google Scholar 

  • Tcheng JE, Harrington RA, Kottke-Marchant K, Kleimen NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, Miller JA, Joseph DM, Sigmon KN, Kitt MM, DuMee CP, Califf RM, Popol EJ (1995) Multicenter, randomized, double blind, placebo-controlled trial of the platelet inte-grin glycoprotein Ilb/IIIa blocker Integrelin in elective coronary intervention. Circulation 91:21512157

    Article  Google Scholar 

  • Topol EJ (1994) Evaluation of C7E3 for the prevention of ischemic complications. Lancet 343:881–886

    Article  PubMed  CAS  Google Scholar 

  • Topol EJ, Fuster V, Harrington RA, Califf RM, Kleimen NS, Kereiakes DJ, Cohen, Chapekis A, Gold HK, Tannenbaum MA, Rao AK, Deboway D, Schwartz D, Henis M, Chesebro J (1994) Recombinant hirudin for unstable angina pectoris. A multicenter randomized angiographic trial. Circulation 89

    Google Scholar 

  • Van den Bos A, Deckers JW, Heyndruckx GR, Laarman GJ, Suryapranata H, Zijlstra F, Close P, Rijnierse JJMM, Buller HR, Serruys PW (1993) Safety and efficacy of recombinant hirudin (CGP 39393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation 88:2058

    Article  PubMed  Google Scholar 

  • Van der Meer FJ, Rosendaal FR, Vandenbroukl JP, Briet E (1992) Bleeding complications in oral anticoagulant therapy. Arch Intern Med 153:1557–1562

    Google Scholar 

  • Wagner T, Schwieder G, Wiedemann G (1987) Kumarinnekrose und Protein C. Hämostaseologie 7:53–56

    Google Scholar 

  • Waibel P (1979) The value of anticoagultion in arterial reconstruction. VASA 8:121

    PubMed  CAS  Google Scholar 

  • Waibel P (1979) The value of anticoagulation in arterial reconstruction. VASA 8:121

    PubMed  CAS  Google Scholar 

  • Waibel P, Geering P (1981) Spätresultate bei Rekonstruktionen wegen Verschlußkrankheit der unteren Extremität. VASA 10:308–309

    PubMed  CAS  Google Scholar 

  • Wankmüller H, Ellbrück D, Seifried E (1991) Pathophysiologie, Klinik und Therapie der Cumarin-Nekrose. Dtsch Med Wochenschr 116:1322–1330

    Article  PubMed  Google Scholar 

  • Weichert W, Meentz H, Abt K, Lieb H, Hach W, Breddin HK (1994) Acetylsalicylicacid-reocclusion-prophylaxis after angioplasty (ARPA-study). A randomized controlled trial of different dosages of ASA in patients with peripheral occlusive arterial disease. VASA 23:57–65

    PubMed  CAS  Google Scholar 

  • Yin ET, Wessler S, Butler J (1973) Plasma heparin: A unique, practical, submicrogram sensitive assay. J Lab Clin Med 81:198–310

    Google Scholar 

  • Zeitler E, Reichold J, Schoop W, Loew D (1973) Einfluß von Acetylsalicylsäure auf das Frühergebnis nach perkutaner Rekanalisation arterieller Obliterationen nach Dotter. Dtsch Med Wochenschr 98:1285–1288

    Article  PubMed  CAS  Google Scholar 

  • Zekert F, Kohn P, Vormittag E (1976) Eine randomisierte Studie über die postoperative Thromboseprophylaxe mit Acetylsalicylsäure. Med Welt 27:1372–1373

    PubMed  CAS  Google Scholar 

  • Zichner R, Weihrauch TR (1989) Zur optimalen Dosierung von Acetylsalicylsäure (ASS). Med Klin 84:43–51

    CAS  Google Scholar 

14.6

  • Ansell J, Slepchuk N jr, Kumar R, Lopez A, Southard L, Deykin D (1980) Heparininduced thrombocytopenia: a prospective study. Thromb Haemostasis 43:61–65

    CAS  Google Scholar 

  • Aster RH (1995) Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332:1374–1376

    Article  PubMed  CAS  Google Scholar 

  • Bell WR, Royall RM (1980) Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 303:902–907

    Article  PubMed  CAS  Google Scholar 

  • Chong BH, Berndt C (1989) Heparin-induced thrombocytopenia. Blut 58:53–57

    Article  PubMed  CAS  Google Scholar 

  • Chong BH (1995) Heparin-induced Thrombocytopenia. Br J Haematology 89:431–439

    Article  CAS  Google Scholar 

  • Fidlar E, Jaques LB (1948) The effect of comercial heparin on platelet count. J Lab Clin Med 33:1410–1414

    PubMed  CAS  Google Scholar 

  • Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW (1994) Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev 46:89–109

    PubMed  CAS  Google Scholar 

  • Greinacher A (1993) Heparin-assoziierte Thrombozytopenien. Diagnose & Labor 43:124–129

    Google Scholar 

  • Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C (1994) Laboratory diagnosis of heparinassociated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381–385

    Article  PubMed  CAS  Google Scholar 

  • Greinacher A (1996) Heparin-induzierte Thrombozytopenien. Internist 37:1172–1178

    PubMed  CAS  Google Scholar 

  • Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet 344:469–470

    PubMed  CAS  Google Scholar 

  • Kalangos A, Relland JY, Massonet Castel S, Acar C, Carpentier A (1994) Heparin-induced thrombocytopenia and thrombosis following open heart surgery. Eur J Cardiothorac Surg 8:199–203

    Article  PubMed  CAS  Google Scholar 

  • Keeling DM, Richards EM, Baglin TP (1994) Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia. Br J Haematol 86:425–426

    Article  PubMed  CAS  Google Scholar 

  • Kelton JG (1986) Heparin-induced thrombocytopenia. Haemostasis 16:173–186

    PubMed  CAS  Google Scholar 

  • Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P (1994) Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232–3239

    PubMed  CAS  Google Scholar 

  • Kemkes-Matthes B (1997) Heparin-induzierte Thrombozytopenie. Arzneimitteltherapie 15:212–214

    Google Scholar 

  • King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100:535–540

    Article  PubMed  CAS  Google Scholar 

  • Kwann HC, Kampmeier PA, Gomez HJ (1981) Incidence of thrombocytopenia during therapy with bovine lung and porcine gut mucosal heparin preparations (Abstract). Thromb Haemostasis 46: 680A

    Google Scholar 

  • Magnani HN (1993) Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 100172). Thromb Haemost 70:554–561

    PubMed  CAS  Google Scholar 

  • Nand S (1997) Heparin-induced thrombocytopenia with thrombosis. Am J Heamatol 56:12–16

    Article  CAS  Google Scholar 

  • O-Yurvati AH, Laub GW, Southgate TJ, McGrath LB (1994) Heparinless cardiopulmonary bypass with ancrod. Ann Thorac Surg 57:1656–1658

    Article  PubMed  CAS  Google Scholar 

  • Powers PJ, Kelton JG, Carter CJ (1984) Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res 33:439–443

    Article  PubMed  CAS  Google Scholar 

  • Schrader J, Haas S (1993) Unfraktioniertes Standardheparin versus niedermolekulare Héparine. Internist 34:1053–1057

    PubMed  CAS  Google Scholar 

  • Shorten GD, Comunale ME (1996) Heparin-induced Thrombocytopenia. J Cardiothoracic Vasc Anesthesia 10:521–530

    Article  CAS  Google Scholar 

  • Warkentin TE, Kelton JG (1991) Heparin-induced Thrombocytopenia. In: Coller BS (ed) Progress in hemostasis and thrombosis. W.B. Saunders Comp. Vol. 10, S. 1-34 Philadelphia.

    Google Scholar 

  • Warkentin TE, Levine MN, Hirsch J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin-induced Thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332-1330-1335

    Google Scholar 

Download references

Authors
  1. H. K. Breddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Th. Karasch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Rieger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Aggertalklinik Engelskirchen, 51766, Engelskirchen, Deutschland

    Horst Rieger

  2. Sonnenbergstraße 6 a, 79117, Freiburg i. Br., Deutschland

    Werner Schoop

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Breddin, H.K., Karasch, T., Rieger, H. (1998). Medikamentöse Prophylaxe bei peripheren arteriellen Durchblutungsstörungen. In: Rieger, H., Schoop, W. (eds) Klinische Angiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08104-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08104-4_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-08105-1

  • Online ISBN: 978-3-662-08104-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation